GENENTECH, INC for GENENTECH INC
What was lobbied
7 issue areas, each in the filer's own words, with who lobbied on it and where.
Food Industry (safety, labeling, etc.) FOO
Monitor food safety and supply chain issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT | — |
| DARIN GARDNER | — |
| ANNA GRIFFIN | — |
| EVAN MORRIS | — |
| KATHERINE RAAB | — |
Taxation/Internal Revenue Code TAX
Monitor and report on corporate tax issues; Monitoring proposals on U.S. tax treatment of foreign corporations; S. 506, Stop Tax Haven Abuse Act;
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT | — |
| DARIN GARDNER | — |
| ANNA GRIFFIN | — |
| EVAN MORRIS | — |
| KATHERINE RAAB | — |
Copyright/Patent/Trademark CPT
Patent Settlement Issues; Intellectual Property and Process Patent Issues;
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT | — |
| DARIN GARDNER | — |
| ANNA GRIFFIN | — |
| EVAN MORRIS | — |
| KATHERINE RAAB | — |
Health Issues HCR
Pandemic Preparedeness: Tamiflu; Advocate on legislative changes in the health care reform bill regarding biosimilars; Monitor changes to outpatient 340B presecription drug discount program, including related provisions included in HR 4213 - American Jobs and Closing Tax Loopholes Act; S. 3793, Job Creation and TAx Cuts Act; All healthcare and biotechnology legislation. Stockpiling of antiviral in preparation of a pandemic, HHS Appropriations bill H.R. 1548 - Pathway for Biosimilars Act FDA Approval and Enforcement Issues Cancer Research Issues S. 3686 FY 2011 Appropriations, HHS HCR issues concerning clinical trials Congressional oversight issues Implementation issues related to the Patient Protection and Affordable Care Act H.R. 1 - Pandemic influenza funding H.R. 1105 Omnibus Appropriations Act, Pandemic Funding Issues Food Safety Bill, H.R. 4872 Health Care and Education Reconciliation Act of 2010 H.R. 3974 Viral Hepatitis and LIver Cancer Control and Prevention Act of 2009 H.R. 3590 Patient Projection and Affordable Care Act-FTC issue Ryan White CARE Act reauthorization S. 726/HR 1427 - Promoting Innovation and Access to Life-Saving Medicine Act Educational meetings in Senate with candiate for Patient Centered Outcomes Research Institute Board (PCORI)
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT | — |
| DARIN GARDNER | — |
| ANNA GRIFFIN | — |
| EVAN MORRIS | — |
| KATHERINE RAAB | — |
Medicare/Medicaid MMM
Implementation of H.R. 1; Medicare Prescription Drug and Modernization Act of 2003; Medicare and Medicaid Coverage and Reimbursement; issues relating to Prescription Drug User Fee Act, stimulus provisions and economic recovery; payment policies for prescription drugs; Issues relating to compaarative effectiveness and follow-on biologics; HR 3200 and America's Healthy Future Act of 2009. Issues related to comparative effectiveness and follow-on biologics;
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT | — |
| DARIN GARDNER | — |
| ANNA GRIFFIN | — |
| EVAN MORRIS | — |
| KATHERINE RAAB | — |
Budget/Appropriations BUD
Following issues related to the budget and appropriations process; Issues related to government purchases of pandemic drugs: Tamiflu; Seek Federal appropriations in the FY11 Labor, Health and Human Services and Education bill regarding pandemic influenza;HIV/AIDS programs and HCV screening, care and treatment; Implementation of H.R. 2346, S. 10554; FY09 Supplemental Appropriations related to preparedness for pandemic influenza; FY11 State Foreign Operations appropriations related to USAID and funding for Pandemic Influenza
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT | — |
| DARIN GARDNER | — |
| ANNA GRIFFIN | — |
| EVAN MORRIS | — |
| KATHERINE RAAB | — |
Homeland Security HOM
Labor HHS Appropriations - S. 3230 and H.R. 3042 Homeland Security Appropriations S.3181 and H.R. 6947
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT | — |
| DARIN GARDNER | — |
| ANNA GRIFFIN | — |
| EVAN MORRIS | — |
| KATHERINE RAAB | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.